Fund Holdings — Logos Global Management LP

Total Portfolio Value:
$1.65B
Total Bought:
$362.43M
Total Sold:
$979.24M
Net Transaction:
-$616.81M
Notable People:
Logos Global Management Gp Llc, Arsani Hany William, Graham Gordon Walmsley
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Praxis Precision Medicines, Inc.(PRAX)260,000425,000+165,000$87.05M$123.77M7.48%+$36.73M
Revolution Medicines, Inc.(RVMD)700,000600,000-100,000$131.10M$123.16M7.44%-$7.94M
IDEAYA Biosciences, Inc.(IDYA)3,000,0002,850,000-150,000$111.81M$109.50M6.62%-$2.31M
Erasca, Inc.(ERAS)12,150,0005,900,000-6,250,000$222.59M$86.49M5.23%-$136.09M
ABIVAX Société AnonymeADS(ABVX)1,024,000870,000-154,000$136.46M$86.15M5.21%-$50.31M
CG Oncology, Inc.(CGON)1,000,000975,000-25,000$71.05M$69.12M4.18%-$1.93M
Disc Medicine, Inc.(IRON)875,0001,015,000+140,000$64.00M$66.44M4.02%+$2.44M
BioNTech SEADS(BNTX)1,015,000650,000-365,000$94.45M$63.90M3.86%-$30.55M
Tango Therapeutics, Inc.(TNGX)2,850,0002,150,000-700,000$89.09M$53.64M3.24%-$35.45M
Madrigal Pharmaceuticals, Inc.(MDGL)0100,000+100,000$0$50.40M3.05%+$50.40M
Enliven Therapeutics Inc465,0001,080,000+615,000$23.60M$49.51M2.99%+$25.91M
Dyne Therapeutics, Inc.(DYN)2,550,0003,000,000+450,000$56.64M$48.33M2.92%-$8.31M
Ocular Therapeutix, Inc.(OCUL)5,300,0006,000,000+700,000$52.05M$46.02M2.78%-$6.03M
Dianthus Therapeutics, Inc.(DNTH)800,000500,000-300,000$77.98M$44.02M2.66%-$33.96M
ArriVent BioPharma, Inc.(AVBP)1,000,0001,350,000+350,000$34.74M$40.88M2.47%+$6.14M
Cogent Biosciences, Inc.(COGT)900,0001,250,000+350,000$34.83M$40.02M2.42%+$5.20M
Neurocrine Biosciences, Inc.(NBIX)0250,000+250,000$0$35.46M2.14%+$35.46M
Belite Bio, IncADS(BLTE)250,000200,000-50,000$38.50M$33.96M2.05%-$4.53M
Axsome Therapeutics, Inc.(AXSM)0175,000+175,000$0$32.27M1.95%+$32.27M
Structure Therapeutics IncADS500,0001,000,000+500,000$26.84M$31.27M1.89%+$4.43M
Olema Oncology, Inc.(OLMA)3,208,8753,208,8750$40.14M$27.72M1.68%-$12.42M
Achieve Life Science Inc5,425,0003,200,000-2,225,000$35.43M$25.89M1.56%-$9.54M
Maze Therapeutics, Inc.(MAZE)1,935,000935,000-1,000,000$57.74M$25.41M1.54%-$32.33M
Parabilis Medicines Inc525,000750,000+225,000$14.37M$24.22M1.46%+$9.85M
Apnimed Inc01,100,000+1,100,000$0$24.10M1.46%+$24.10M
Yarrow Bioscience Inc01,026,258+1,026,258$0$23.11M1.40%+$23.11M
Trevi Therapeutics, Inc.(TRVI)1,880,0001,445,000-435,000$35.06M$20.69M1.25%-$14.37M
Veradermics, Incorporated(MANE)180,000170,000-10,000$22.13M$20.61M1.25%-$1.52M
Vera Therapeutics, Inc.CL A(VERA)2,200,000600,000-1,600,000$94.40M$19.37M1.17%-$75.03M
Sarepta Therapeutics, Inc.(SRPT)01,000,000+1,000,000$0$18.22M1.10%+$18.22M
MoonLake ImmunotherapeuticsCL A(MLTX)2,675,0001,500,000-1,175,000$52.08M$17.55M1.06%-$34.53M
Immunocore Holdings plcADS(IMCR)600,000500,000-100,000$19.05M$15.14M0.92%-$3.90M
Biohaven Ltd.(BHVN)01,100,000+1,100,000$0$14.69M0.89%+$14.69M
CRISPR Therapeutics AGNAMEN AKT(CRSP)300,000250,000-50,000$16.36M$13.83M0.84%-$2.53M
Definium Therapeutics, Inc.(DFTX)80,000350,000+270,000$3.76M$13.32M0.81%+$9.56M
Entera Bio Ltd.SHS(ENTX)04,411,764+4,411,764$0$12.84M0.78%+$12.84M
Design Therapeutics, Inc.(DSGN)3,000,0001,000,000-2,000,000$43.41M$12.57M0.76%-$30.84M
Crescent Biopharma, Inc.(CBIO)1,900,000850,000-1,050,000$34.20M$12.40M0.75%-$21.80M
Electra Therapeutics Inc01,000,000+1,000,000$0$11.25M0.68%+$11.25M
Minerva Neurosciences, Inc.(NERV)3,288,7773,288,7770$18.25M$11.02M0.67%-$7.24M
LB Pharmaceuticals Inc(LBRX)585,000250,000-335,000$18.99M$9.60M0.58%-$9.39M
Viking Therapeutics, Inc.(VKTX)0200,000+200,000$0$6.52M0.39%+$6.52M
Editas Medicine, Inc.(EDIT)2,222,0002,222,0000$7.20M$5.71M0.35%-$1.49M
Tonix Pharmaceuticals Holding Corp.(TNXP)0550,000+550,000$0$5.36M0.32%+$5.36M
Opus Genetics, Inc.(IRD)01,000,000+1,000,000$0$4.84M0.29%+$4.84M
Vogenx Inc0205,000+205,000$0$4.67M0.28%+$4.67M
Immunovant, Inc.(IMVT)665,00085,000-580,000$25.62M$2.87M0.17%-$22.75M
Jade Biosciences Inc1,125,000200,000-925,000$25.00M$2.81M0.17%-$22.19M
OnKure Therapeutics, Inc.CL A(OKUR)963,855963,8550$4.40M$2.63M0.16%-$1.77M
Tcgx Acquisition CorpCL A0200,000+200,000$0$2.50M0.15%+$2.50M
Unicycive Therapeutics, Inc.(UNCY)473,563473,5630$2.22M$2.22M0.13%+$2.4K
Palatin Technologies, Inc.(PTN)130,000129,260-740$1.40M$1.15M0.07%-$256.2K
Jatt Ii Acquisition Corp100,000100,0000$1.14M$1.12M0.07%-$11.5K
Jatt Iii Acquisition Corp0100,000+100,000$0$1.10M0.07%+$1.10M
Research Alliance Corp IiiCL A100,000100,0000$1.07M$1.08M0.07%+$13.0K
Septerna, Inc.(SEPN)23,54823,5480$788.6K$921.4K0.06%+$132.8K
Amanat Acquisition CorpCL A50,00050,0000$508.0K$534.0K0.03%+$26.0K
Longeveron IncCL A0192,308+192,308$0$517.3K0.03%+$517.3K
Fractyl Health, Inc.(GUTS)1,000,000504,965-495,035$794.4K$274.9K0.02%-$519.5K
Acadia Pharmaceuticals Inc250,0000-250,000$6.33M$0—-$6.33M
Aclaris Therapeutics, Inc.(ACRS)200,0000-200,000$1.06M$0—-$1.06M
Amylyx Pharmaceuticals, Inc.(AMLX)350,0000-350,000$6.29M$0—-$6.29M
Annexon, Inc.(ANNX)1,500,0000-1,500,000$8.56M$0—-$8.56M
Arcus Biosciences, Inc.(RCUS)650,0000-650,000$20.04M$0—-$20.04M
Avalo Therapeutics, Inc.(AVTX)1,150,0000-1,150,000$21.25M$0—-$21.25M
Celldex Therapeutics, Inc.(CLDX)2,100,0000-2,100,000$78.14M$0—-$78.14M
COMPASS Pathways plcADS(CMPS)2,250,0000-2,250,000$31.84M$0—-$31.84M
Helus Pharma Inc(HELP)750,0000-750,000$4.96M$0—-$4.96M
DBV Technologies S.A.ADS(DBVT)915,0000-915,000$15.01M$0—-$15.01M
Faeth Therapeutics, Inc.(FTH)722,0200-722,020$18.05M$0—-$18.05M
Immix Biopharma, Inc.(IMMX)1,000,0000-1,000,000$10.31M$0—-$10.31M
Longeveron Inc.CL A(LGVN)1,287,0000-1,287,000$904.8K$0—-$904.8K
Mineralys Therapeutics, Inc.(MLYS)1,050,0000-1,050,000$28.33M$0—-$28.33M
Odyssey Therapeutics Inc521,7360-521,736$9.76M$0—-$9.76M
Q32 Bio Inc.(QTTB)800,0000-800,000$10.19M$0—-$10.19M
Relay Therapeutics, Inc.(RLAY)350,0000-350,000$6.55M$0—-$6.55M
Replimune Group, Inc.(REPL)2,500,0000-2,500,000$27.68M$0—-$27.68M
Rhythm Pharmaceuticals, Inc.(RYTM)125,0000-125,000$13.88M$0—-$13.88M
Scholar Rock Holding Corporation(SRRK)200,0000-200,000$11.00M$0—-$11.00M
Summit Therapeutics Inc.(SMMT)1,350,0000-1,350,000$19.67M$0—-$19.67M
Tenax Therapeutics, Inc.(TENX)300,0000-300,000$4.37M$0—-$4.37M
uniQure N.V.SHS(QURE)30,0000-30,000$1.38M$0—-$1.38M
Vor Biopharma Inc.(VOR)650,0000-650,000$11.97M$0—-$11.97M
Xenon Pharmaceuticals Inc.(XENE)450,0000-450,000$27.16M$0—-$27.16M
Page 1 of 1
Logos Global Management LP — 13F Holdings — Q3 2026 | TickerTrail